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STAT3, these results could not be observed. In vivo results demonstrated that
after surgery of hindlimb ischemia, mice (n¼12) treated with JI-34 pretreated
MSC, MSC and PBS revealed a signiﬁcantly difference of limb recovery and
rebuildment of newly formed vessels. Ultrasound Doppler displayed that mice
injected with treated cells gained a better recovery of blood perfusion in day 3
after surgery and sustained to day14 than MSC and PBS group. Immunoﬂuo-
rescence of CD31, a-SMA, TUNEL and immunohistochemistry also supported
the results that treated with JI-34, MSC increased vascularation and angio-
genesis of mice hindlimb ischemia.
Conclusions: the agonist of GHRH can activate the receptor of MSC to enhance its
viability and paracrine effect through STAT3 signaling pathway to promote the
angiogenesis of ischemic hindlimb of mice.
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Objectives: Myocardial ischemia-reperfusion injury is a major cause of cardiac
damage following revascularization in acute myocardial infarction. Hydrogen Sulﬁde
(H2S) has emerged as a critical signaling molecule with a profound cardioprotective
effect. However, systemic delivery of H2S is hampered by cytotoxicity. We hypoth-
esized that intravenous administration of microbubbles encapsulating H2S gas com-
bined with ultrasound exposure permit safe and local release of H2S and attenuate
myocardial ischemic-reperfusion injury.
Methods: A 1:1 mixture of the H2S (4ml) and perﬂuorocarbons (4ml) was encap-
sulated into microbubbles (H2S-MB), while microbubbles containing 8ml of
perﬂuorocarbons (PESDA) served as control. Wistar rats were subjected to tempo-
rary ligation of the left coronary artery for 45min. H2S-MB or PESDA were
administered intravenously 5min prior to reperfusion for 10min with or without
ultrasound applied over the heart. H2S concentrations were measured in plasma and
tissue homogenate (heart, lung, kidney and brain) by methylene blue assay. Infarct
size was determined by evans blue and TTC staining. Serum levels of the cardiac-
speciﬁc isoform of troponin-I (cTnI) were assessed 4h after reperfusion. Left ven-
tricular structure and function was assessed by echocardiography 3 weeks after
reperfusion.
Results: Intravenous H2S-MB administration in combination with the ultrasound
exposure enhanced the concentrations of H2S in the myocardial and lung tissue
(P<0.05). Rats receiving H2S-MB and ultrasound representing a signiﬁcant reduction
in infarct size and serum levels of cTnI as compared with PESDA and ultrasound
treated rats (28.02.6% vs 44.64.5%, P¼0.005; 7.61.5 ng/ml vs 13.32.0 ng/ml,
P¼0.019, respectively). There were signiﬁcant differences in ejection fraction between
H2S-MB group and PESDA group both treated with ultrasound exposure (48.61.5%
vs 41.02.0%, P¼0.006). No signiﬁcant hemodynamic differences between H2S-MB
and PESDA were observed.
Conclusions: Targeted delivery of H2S using ultrasound and intravenous micro-
bubbles limits the extent of myocardial ischemia-reperfusion injury. This may provide
a noninvasive strategy for targeted delivery of a therapeutic gas to protect myocardial
injury from ischemia–reperfusion, avoiding systemic side effects.
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Objectives: To observe vasomotor effect of salidroside (SAL) on rat mesenteric ar-
tery, and to explore its underlying regulatory mechanisms.
Methods: Tension was measured by DMT 610M system to evaluate the vasomotor
effect of SAL on rat endothelium-intact and endothelium-denuded mesenteric artery
rings. L-NAME, an inhibitor of nitric oxide synthase (NOS), indomethacin, a
Cyclooxygenase (COX) inhibitor, calcium deprivation and calcium addition were
used to illustrate the mechanisms of vasomotor effect of SAL.
Results: ① SAL (10-8mol/L - 10-4 mol/L) neither had signiﬁcant effect on mesenteric
artery rings keeping the basic state nor ones precontracted by KCl (610-2mol/L)
(P>0.05).② SAL relaxed endothelium-intact and endothelium-denuded mesenteric
artery precontracted by phenylephrine (210-6mol/L) in concentration-dependent
manner, while the vasodilation of endothelium-intact mesenteric artery was signiﬁ-
cantly stronger than that of endothelium-denuded one (P<0.01 in 10-5 mol/L SAL
and P<0.001 in 10-4 mol/L SAL). ③ Pretreatment with L-NAME (10-4mol/L), for
30min signiﬁcantly attenuated the vasodilation of endothelium-intact mesenteric
artery induced by SAL (P<0.01 in 10-5mol/L SAL), while pretreatment with indo-
methacin (10-4mol/L), for 30 min had no effect on the vasodilation of endothelium-
intact mesenteric artery induced by SAL (P>0.05). ④ With calcium deprivation and
calcium addition, SAL relaxed endothelium-denuded mesenteric artery precontracted
by phenylephrine (210-6mol/L) (P<0.01 in 10-5 mol/L SAL), while SAL had no
effect on the increasing tension of mesenteric artery induced by adding CaCl2
(P>0.05).JACC Vol 64/16/Suppl C j October 16–19, 2014 j GW-ICC Abstracts/BConclusions: These results indicate that SAL has endothelium-dependent relax-
ation effect on rat mesenteric artery, which might be related to the endothelial
nitric oxide (NO) pathway and inhibiting release of intracelluar calcium of rat
mesenteric artery. However, this vasodilation effect of SAL is not associated
with voltage-dependent calcium channel, the COX pathway and inﬂux of
extracellular calcium.
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Objectives: To explore the dynamic variance of the reperfusion injury salvage kinase
and mitochondrial permeability transition pore after ischemic postconditioning in
myocardial ischemia-reperfusionon in rats.
Methods: Lewis rats were randomly assigned to a ischemia-reperfusion or ischemic
postconditioning or sham operation protocol. All groups except sham operation group
underwent myocardial ischemia obtained by ligating anterior descending (LAD)
branch for 30min, and followed by 3, 6, 12, 24-hour and 2, 4, 7-day reperfusion
respectively.In ischemic postconditioning group, three cycles of 10s reperfusion fol-
lowed by 10s LAD re-occlusion were applied during the ﬁrst min of reperfusion. the
expression of P-AKT and P-ERK1/2 protein were mearsured by western blot, and
Spectrophotometer was used to determined the opening of mPTP at the end of the
reperfusion respectively.
Results: Compared with sham operation group, the expression of P-AKT and
P-ERK1/2 protein and the opening of mPTP increased (P<0.01) in both ischemia-
reperfusion group and ischemic postconditioning group at 3, 6, 12, 24-hour and 2, 4,
7-day reperfusion. Compared with ischemia-reperfusion group, the expression of
P-AKT and P-ERK1/2 protein increased (P<0.05), the opening of mPTP decreased
(P<0.05) in ischemic postconditioning group. In both ischemia-reperfusion group and
ischemic postconditioning group, no change in the trend of the expression of P-AKT
and P-ERK1/2 protein and the opening of mPTP, and the peak-time of expression of
P-AKT and P-ERK1/2 protein and the trough-time of opening of mPTP happened at
24h reperfusion.
Conclusions: Ischemic postconditioning increases the expression of P-AKT and
P-ERK1/2 protein, decreases the opening of mPTP between 3 hours and 7 days after
the reperfusion followed myocardial ischemia in rats. However, ischemic post-
conditioning does not change the trend in the expression of P-AKT and P-ERK1/2
protein and the opening of mPTP in ischemia-reperfusionon rats.
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Objectives: Traditional Chinese Medicine (TCM) is one of the oldest organized
healing systems in the human history. The TCM approach to the disease differs from
that of western medicine since it is based on the holistic view of both the diseased
state and the associated therapy; modern western medicine focusses instead on the
identiﬁcation and treatment of speciﬁc molecular causes. Both approaches have a
long history of proven results. We therefore started a collaborative project to
investigate the molecular effects of a TCM drug (Tong Mai Yang Xin, TMYX, Le
Ren Tang, China) which is indicated in the treatment of brady- and tachy-arrhyth-
mias. The speciﬁc aim was to investigate whether this drug acts on the sinoatrial
node (SAN).
Methods: Experiments were carried out in cells isolated from rabbit SAN. The
whole-cell patch-clamp technique was used to record the spontaneous activity of
SAN myocytes in the absence and in the presence of TMYX. Based on the in-vitro
toxicity MTT test carried out on a cardiac cell line (H9C2) and on pilot electro-
physiological experiments, we chose to investigate the action of the drug in the
concentration range 0.02-2 mg/ml. The drug was dissolved in dimethyl sulfoxide
(DMSO) and therefore an appropriate amount of DMSO was also added to the
control solution. Action Potentials (AP) were acquired from regularly beating
single cells or cell-aggregates and analyzed by a customized software. Group
comparisons were carried out by paired t-test statistic (statistical signiﬁcance at
P<0.05).
Results: Stable spontaneous APs were recorded from SAN cells/aggregates before
and during perfusion of TMYX. The parameters that describe the properties of each
AP cycle were the following: 1) AP Rate, Maximum Diastolic Potential (MDP), Early
Diastolic Depolarization (EDD), Take-Off Potential (TOP), AP Duration at 50% of
repolarization (APD50). Speciﬁc details are provided in (1).
When SAN cells were challenged with 3 different concentrations (0.02, 0.2, and
0.6 mg/ml) of TMYX we observed in all cases a signiﬁcant (P<0.05) dose-dependentasic and Translational Medicine C67
